Larvol Delta - BERG-to-Present-Phase-1-Results-of-BPM-31510IV-and-Identies-Therapeutic-Opportunities-for-Recurrent-GBM-Patients-at-2021-American-Society-of-Clinical-Oncology-ASCO-Meeting

ubidecarenone IV (BPM 31510 IV) - Berg

https://www.prnewswire.com/news-releases/berg-to-present-phase-1-results-of-bpm-31510-iv-and-identifies-therapeutic-opportunities-for-recurrent-gbm-patients-at-2021-american-society-of-clinical-oncology-asco-meeting-301303793.html

Jun 2, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next